Recombinant Monoclonal Anti-ALPP Antibody, Mouse (1B10)

Customer Reviews
Cat. No. / Size
Price
Qty
HCS-S312-20ul
$130.00
HCS-S312-100ul
$450.00
ETA of in-stock products:2 business days

Product Details

  • Background

    Recombinant Monoclonal Anti-ALPP Antibody, Mouse (1B10) is an ALPP primary antibody for IHC application. Alkaline Phosphatase plays an important role in the regulation of specific inflammatory disease processes. Placental Alkaline Phosphatase has been linked directly to hypophosphatasia, a disorder that is characterized by hypercalcemia and includes skeletal defects.

  • Product Specifications

    Host Species
    Mouse
    Isotype
    Mouse IgG1, Mouse Kappa
    Clone
    1B10
    Application
    IHC-P
    Dilution Ratio
    1: 1000 - 1: 2000
    Form
    Liquid
    Clonality
    Monoclonal
    Reactivity
    Human
    Synonyms
    PLAP
    Concentration
    0.9~1.1 mg/ml
    Specificity
    React with ALPP protein on the membrane of target cell/tissue
    Purification Tech
    Protein A
    Preservation
    PBS, BSA, Glycerol
  • Experiment Protocol

    LEICA Experiment Protocol

  • Storage

    Shipped at 4°C, Blue Ice. Store at +4°C for short term (1-2 weeks). Store at -20°C for long term.
    Avoid freeze / thaw cycle. Upon delivery aliquot. The shelf life is 30 days from the date of opening.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • Sample Staining Data

     ALPP SAMPLE STAINING DATA
  •  ALPP SAMPLE STAINING DATA

    Immunohistochemical analysis of paraffin embedded human cancer tissue labelled with HCS-S312 at 1/1500 dilution.
    Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Customer Reviews
Writing Reviews

Recent Advances

 
Drug Development Progress
  • English Name:

    Alkaline phosphatase, placental type

  • Category:

  • Approved Drugs:

    0 Details

  • Drugs in Clinical Trials:

    1 Details

  • Highest Development Stage:

    Phase 2 Clinical

Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews